Metformin + Glimepiride ER Tablets for Diabetes Treatment

/

Metformin + Glimepiride ER Tablets are one of the most widely prescribed oral antidiabetic medicines used for Type-2 Diabetes Mellitus. The combination improves insulin sensitivity, lowers hepatic glucose production, and provides long-duration blood sugar control due to its extended-release mechanism. With diabetes cases increasing globally, demand for this formulation continues to grow — and Kureasia Pharma plays a leading role in manufacturing, bulk supply, third-party, and contract manufacturing services for this essential drug class.

Kureasia Pharma follows quality-driven processing using certified APIs, compliant machinery, and a structured testing environment to ensure consistent results. Our aim is to support healthcare distributors, pharmaceutical companies, and international importers with reliable manufacturing for Metformin + Glimepiride ER Tablets tailored to large-scale supply requirements.

Metformin + Glimepiride ER Tablets manufactured by Kureasia Pharma for bulk export, third-party and contract manufacturing.

Third-Party Manufacturing for Metformin + Glimepiride ER Tablets

Kureasia Pharma provides third-party manufacturing services for Metformin + Glimepiride ER Tablets to companies seeking fast market entry without investing in production infrastructure. Our facility handles formulation, compression, coating, blistering, testing, and final dispatch with compliance and efficiency.

Why clients choose Kureasia Pharma for third-party manufacturing:

  • WHO-GMP compliant production environment

  • Extended-release formulation with better glycemic control

  • Fast turnaround time and smooth process flow

  • Flexible order quantities for startups and large companies

  • Strong quality control with batch-wise documentation

You place your manufacturing requirements — we execute them with accuracy, consistency, and timely delivery.

Contract Manufacturing for Metformin + Glimepiride ER Tablets

Kureasia Pharma also supports pharmaceutical companies through contract manufacturing, offering customized formulation development, consistent production capacity, and long-term supply partnerships. We manage everything from process design to packaging, following strict technical checks and validation standards.

Contract manufacturing highlights:

  • Customizable strengths & formulation based on requirement

  • Approved raw material sourcing with certified vendors

  • Dissolution, assay, and stability-controlled batches

  • Regulatory support for market registration and export

  • Scalable capacity for high-volume recurring orders

Our contract manufacturing partnerships are built on confidentiality, quality assurance, and sustainability.

Bulk Supply for International Markets (Nigeria & Iraq)

Kureasia Pharma is equipped for bulk and wholesale supply of Metformin + Glimepiride ER Tablets with robust export capability. We currently cater to multiple global importers, specifically in Nigeria and Iraq, where diabetic medication requirements are rapidly expanding.

Export and bulk supply advantages:

  • Large-volume production ensuring continuous availability

  • Safe export-grade packaging for long-distance transit

  • Competitive wholesale pricing for bulk procurement

  • Quality certification & export documentation assistance

  • Air & sea shipment support for faster supply timelines

Our efficiency, reliability, and compliance make us a strong sourcing partner for diabetic care medicines globally.

Benefits & Therapeutic Role of Metformin + Glimepiride ER

  • Controls blood glucose for longer periods

  • Improves insulin utilization in peripheral tissues

  • Reduces hepatic glucose output

  • Supports long-term Type-2 diabetes management

  • Better dosage compliance due to extended release

This combination is widely recommended when lifestyle modifications and monotherapy are insufficient to maintain desired sugar levels.

Why Partner With Kureasia Pharma?

Kureasia Pharma prioritizes responsible manufacturing and committed business partnerships. Our dedication to quality makes us one of the preferred producers of diabetic care formulations.

With us, you get:

  • Bulk supply + Third-party + Contract manufacturing under one facility

  • Strict quality validation and high-purity formulation output

  • Export-ready production for Nigeria, Iraq & more

  • Modern processing, high capacity & timely dispatch

  • Long-term collaboration focused on business growth

We ensure consistent quality, stable performance, and dependable manufacturing at every stage.

Frequently Asked Questions (FAQs)
Do you offer third-party manufacturing for Metformin + Glimepiride ER Tablets?

Yes, Kureasia Pharma provides complete third-party manufacturing services with quality assurance and batch documentation.

 

Yes, we offer bulk production and export of Metformin + Glimepiride ER Tablets specifically supplying to Nigeria and Iraq.

 

Common combinations include Metformin ER 500mg/1000mg with Glimepiride 1mg/2mg. Custom strengths can be produced based on requirement.

 

Because we provide customized formulations, scalable production, regulatory guidance, and reliable recurring supply support.

Partner With Kureasia Pharma for Consistent Quality & Reliable ManufacturingWhether you require third-party manufacturing, contract manufacturing, or bulk export supply, Kureasia Pharma is equipped to meet your demand for Metformin + Glimepiride ER Tablets with high precision and dependable continuity.

Office Info

+91 95577 45784
+91 93110 19560
011-40234824
sales@kureasiapharma.com
B- 255,Third Floor, Munshi Ram Gupta Marg, Naraina Industrial Area Phase 1, New Delhi 110028
Industrial Area, Plot Number-1, Khasra No. 882, 883k, Village-Salempur, Mehdood-II, Haridwar 249402, INDIA